UPHEALTH INC (UPH) Fundamental Analysis & Valuation
NYSE:UPH • US91532B2007
Current stock price
0.3 USD
+0.03 (+9.13%)
Last:
This UPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. UPH Profitability Analysis
1.1 Basic Checks
- UPH had negative earnings in the past year.
- UPH had a negative operating cash flow in the past year.
1.2 Ratios
- UPH has a Return On Assets (-31.98%) which is comparable to the rest of the industry.
- UPH has a Return On Equity of -117.29%. This is in the lower half of the industry: UPH underperforms 62.79% of its industry peers.
- UPH has a better Return On Invested Capital (1.59%) than 86.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.98% | ||
| ROE | -117.29% | ||
| ROIC | 1.59% |
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Operating Margin value of 0.90%, UPH belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
- With a Gross Margin value of 45.52%, UPH is not doing good in the industry: 60.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.9% | ||
| PM (TTM) | N/A | ||
| GM | 45.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. UPH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UPH is destroying value.
- UPH has more shares outstanding than it did 1 year ago.
- The debt/assets ratio for UPH is higher compared to a year ago.
2.2 Solvency
- UPH has an Altman-Z score of -3.70. This is a bad value and indicates that UPH is not financially healthy and even has some risk of bankruptcy.
- UPH's Altman-Z score of -3.70 is on the low side compared to the rest of the industry. UPH is outperformed by 67.44% of its industry peers.
- UPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.03, UPH is doing good in the industry, outperforming 69.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.7 |
ROIC/WACC0.24
WACC6.53%
2.3 Liquidity
- UPH has a Current Ratio of 0.13. This is a bad value and indicates that UPH is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.13, UPH is doing worse than 97.67% of the companies in the same industry.
- A Quick Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
- With a Quick ratio value of 0.13, UPH is not doing good in the industry: 97.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.13 |
3. UPH Growth Analysis
3.1 Past
- UPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.97%, which is quite impressive.
- UPH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%
3.2 Future
- UPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.89% yearly.
- UPH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.68% yearly.
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A
3.3 Evolution
4. UPH Valuation Analysis
4.1 Price/Earnings Ratio
- UPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UPH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, UPH is valued cheaper than 90.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.37 |
4.3 Compensation for Growth
- UPH's earnings are expected to grow with 23.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y23.89%
5. UPH Dividend Analysis
5.1 Amount
- No dividends for UPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
UPH Fundamentals: All Metrics, Ratios and Statistics
NYSE:UPH (12/11/2023, 8:20:46 PM)
0.3
+0.03 (+9.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-20 2023-11-20/amc
Earnings (Next)02-29 2024-02-29/amc
Inst Owners0.11%
Inst Owner Change61211.9%
Ins Owners112.9%
Ins Owner Change0%
Market Cap5.33M
Revenue(TTM)153.15M
Net Income(TTM)-75.18M
Analysts82.5
Price Target5.24 (1646.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-362.92%
Min EPS beat(2)-624.95%
Max EPS beat(2)-100.89%
EPS beat(4)1
Avg EPS beat(4)-206.44%
Min EPS beat(4)-624.95%
Max EPS beat(4)19.85%
EPS beat(8)3
Avg EPS beat(8)-213.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.44%
Min Revenue beat(2)13.83%
Max Revenue beat(2)15.05%
Revenue beat(4)4
Avg Revenue beat(4)11.19%
Min Revenue beat(4)0.81%
Max Revenue beat(4)15.06%
Revenue beat(8)4
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.55%
PT rev (3m)-14.55%
EPS NQ rev (1m)43.5%
EPS NQ rev (3m)43.5%
EPS NY rev (1m)-11.26%
EPS NY rev (3m)-11.26%
Revenue NQ rev (1m)12.58%
Revenue NQ rev (3m)112482%
Revenue NY rev (1m)5.99%
Revenue NY rev (3m)5.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.03 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.37 |
EPS(TTM)-7.7
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS8.61
BVpS3.61
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.98% | ||
| ROE | -117.29% | ||
| ROCE | 2.01% | ||
| ROIC | 1.59% | ||
| ROICexc | 1.67% | ||
| ROICexgc | N/A | ||
| OM | 0.9% | ||
| PM (TTM) | N/A | ||
| GM | 45.52% | ||
| FCFM | N/A |
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.12 | ||
| Cap/Depr | 37.34% | ||
| Cap/Sales | 3.21% | ||
| Interest Coverage | 0.09 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.13 | ||
| Altman-Z | -3.7 |
F-Score5
WACC6.53%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A
EBIT growth 1Y102.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.28%
EBIT Next 3Y43.77%
EBIT Next 5YN/A
FCF growth 1Y45.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.9%
OCF growth 3YN/A
OCF growth 5YN/A
UPHEALTH INC / UPH Fundamental Analysis FAQ
What is the ChartMill fundamental rating of UPHEALTH INC (UPH) stock?
ChartMill assigns a fundamental rating of 1 / 10 to UPH.
What is the valuation status of UPHEALTH INC (UPH) stock?
ChartMill assigns a valuation rating of 1 / 10 to UPHEALTH INC (UPH). This can be considered as Overvalued.
What is the profitability of UPH stock?
UPHEALTH INC (UPH) has a profitability rating of 2 / 10.
What is the financial health of UPHEALTH INC (UPH) stock?
The financial health rating of UPHEALTH INC (UPH) is 1 / 10.